CUH Logo

Mobile menu open

Board of directors' meeting - 11 March 2026

Events

There will be a meeting of the CUH Board of Directors on Wednesday 11 March 2026 commencing at 3.00pm and will be held in the Committee Room, School of Clinical Medicine, Addenbrooke's Hospital, Hills Rd, Cambridge, CB2 0SP. Microsoft Teams videoconference details will also be available.

If you would like to attend the Board meeting, please email: cuh.trustsecretariat@nhs.net providing your name and your organisation/role if applicable and email address by no later than 12noon on Friday 6th March 2026 (3 clear working days prior to the meeting).

If you would like to submit a question, please do so by emailing: cuh.trustsecretariat@nhs.net by 12 noon on Friday, 6th March 2026.

  • Questions from members of the public will be limited to 1 question per person/organisation and should be no more than 100 words in length.
  • Questions must only relate to matters within the powers and functions of the CUH Board of Directors.
  • Any questions received following the deadline date will be deferred and considered for the next most relevant Board meeting.

The Chair reserves the right to refuse written questions that are not within the powers and duties of the Trust to answer. The Chair may decide to not deal with complex or lengthy subjects in the question and answer session and may choose to respond with written answers only. The Chair has discretion on whether a question can be submitted to answer.

Please see the following link for further details: Board of directors meetings (opens in a new tab).

Questions and responses

Question

The chair of the BMA has advised members to support a complete break from the use of Palantir Technologies Inc within the NHS owing to its amoral record with the US ICE and sales of arms and surveillance equipment used to murder Palestinian civilians, including children and babies. Also serious risks to patient data-security have been identified.

Given the above and the links between Palantir and the disgraced Epstein and Mandelson, patients need assurance that this corporation will not have access to their confidential records. Will the Board confirm that all contracts with Palantir will be rejected?

Response:

The NHS England Medium Term Planning Framework requires all NHS healthcare providers to use the NHS FDP.

CUH is working with our regional healthcare partners to use OPTICA, which is part of the NHS FDP, to support complex patient discharges. We anticipate being live with this in early 2026. This will help to deliver the best care to our patients through national publicly funded systems, enhancing coordination between hospital and community care teams in our areas - helping our patients to transition from hospital to community care faster and more safely.

We are aware of some concerns raised about the supplier of the NHS FDP. The supplier was procured by NHS England through an independent and transparent procurement process in line with public contract regulation and legislation. Cambridge University Hospitals NHS Foundation Trust was not involved in this procurement process. 

Please see our website for further information NHS Federated Data Platform | CUH

Board